1. Home
  2. IKT vs SRI Comparison

IKT vs SRI Comparison

Compare IKT & SRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKT
  • SRI
  • Stock Information
  • Founded
  • IKT 2008
  • SRI 1965
  • Country
  • IKT United States
  • SRI United States
  • Employees
  • IKT N/A
  • SRI N/A
  • Industry
  • IKT Biotechnology: Pharmaceutical Preparations
  • SRI Auto Parts:O.E.M.
  • Sector
  • IKT Health Care
  • SRI Consumer Discretionary
  • Exchange
  • IKT Nasdaq
  • SRI Nasdaq
  • Market Cap
  • IKT 159.2M
  • SRI 182.6M
  • IPO Year
  • IKT 2020
  • SRI 1997
  • Fundamental
  • Price
  • IKT $2.31
  • SRI $6.62
  • Analyst Decision
  • IKT Strong Buy
  • SRI Buy
  • Analyst Count
  • IKT 2
  • SRI 2
  • Target Price
  • IKT $6.50
  • SRI $16.00
  • AVG Volume (30 Days)
  • IKT 310.9K
  • SRI 404.5K
  • Earning Date
  • IKT 11-14-2024
  • SRI 10-30-2024
  • Dividend Yield
  • IKT N/A
  • SRI N/A
  • EPS Growth
  • IKT N/A
  • SRI N/A
  • EPS
  • IKT N/A
  • SRI N/A
  • Revenue
  • IKT $1.00
  • SRI $919,562,000.00
  • Revenue This Year
  • IKT N/A
  • SRI N/A
  • Revenue Next Year
  • IKT N/A
  • SRI $6.35
  • P/E Ratio
  • IKT N/A
  • SRI N/A
  • Revenue Growth
  • IKT N/A
  • SRI N/A
  • 52 Week Low
  • IKT $0.85
  • SRI $5.90
  • 52 Week High
  • IKT $3.82
  • SRI $19.91
  • Technical
  • Relative Strength Index (RSI)
  • IKT 52.09
  • SRI 34.99
  • Support Level
  • IKT $1.75
  • SRI $5.90
  • Resistance Level
  • IKT $2.10
  • SRI $7.64
  • Average True Range (ATR)
  • IKT 0.33
  • SRI 0.37
  • MACD
  • IKT -0.10
  • SRI 0.04
  • Stochastic Oscillator
  • IKT 28.87
  • SRI 33.89

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. Stoneridge generates the majority of its revenue in its Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Geographically, the company's operations are focused on North America. It has Control Devices, Electronics, and Stoneridge Brazil segments.

Share on Social Networks: